Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided High Dose Rate brachytherapy boost

Radiation Oncology

Volumn 1, Issue 1, 2006, Pages

  Singh, Anurag K ^a   Guion, Peter ^a   Susil, Robert C ^a   Citrin, Deborah E ^a   Ning, Holly ^a   Miller, Robert W ^a   Ullman, Karen ^a   Smith, Sharon ^a   Crouse, Nancy Sears ^a   Godette, Denise J ^a   Stall, Bronwyn R ^a   Coleman, C Norman ^a   Camphausen, Kevin ^a   Ménard, Cynthia ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BIOSYNTHESIS; BRACHYTHERAPY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PILOT STUDY; PROSTATE TUMOR; RADIATION DOSE; RADIOTHERAPY; RISK; TREATMENT OUTCOME;

AGED; BRACHYTHERAPY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PILOT PROJECTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RISK; TREATMENT OUTCOME;

EID: 34248380823     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-1-28     Document Type: Article

References (30)

1. Greenlee RT Hill-Harmon MB Murray T Cancer statistics, 2001 CA Cancer J Clin 2001 51 15-36 11577478
2. Kumar PP Bartone FF Transperineal percutaneous I-125 implant of prostate Urology 1981 17 238-240 10.1016/0090-4295(81)90037-6 7210373
3. Ragde H Blasko JC Grimm PD Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma Cancer 1997 80 442-453 10.1002/ (SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X 9241078
4. Sylvester JE Blasko JC Grimm PD Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: The Seattle experience Int J Radiat Oncol Biol Phys 2003 57 944-952 10.1016/S0360-3016(03)00739-9 14575824
5. Merrick GS Butler WM Wallner KE Variability of prostate brachytherapy pre-implant dosimetry: A multi-institutional analysis Brachytherapy 2005 4 241-251 10.1016/j.brachy.2005.05.002 16344253
6. Critz FA Williams WH Levinson AK Simultaneous irradiation for prostate cancer: Intermediate results with modern techniques J Urol 2000 164 738-741 discussion 741-733 10.1016/S0022-5347(05)67293-X 10953137
7. Astrom L Pedersen D Mercke C Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer Radiother Oncol 2005 74 157-161 10.1016/j.radonc.2004.10.014 15734203
8. Deger S Boehmer D Turk I High dose rate brachytherapy of localized prostate cancer Eur Urol 2002 41 420-426 10.1016/S0302-2838(02)00016-7 12074814
9. Martinez AA Gustafson G Gonzalez J Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer Int J Radiat Oncol Biol Phys 2002 53 316-327 10.1016/ S0360-3016(02)02733-5 12023135
10. Galalae RM Martinez A Mate T Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer Int J Radiat Oncol Biol Phys 2004 58 1048-1055 10.1016/j.ijrobp.2003.08.003 15001244
11. Albertsen PC Hanley JA Penson DF Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation J Urol 2004 171 2221-2225 10.1097/01.ju.0000124381.93689.b4 15126789
12. Cheung R Tucker SL Lee AL Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy Int J Radiat Oncol Biol Phys 2005 61 14-19 10.1016/j.ijrobp.2004.04.064 15629589
13. Ciezki JP Reddy CA Garcia J PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time Int J Radiat Oncol Biol Phys 2006 64 512-517 10.1016/j.ijrobp.2005.07.960 16213667
14. Zietman AL Christodouleas JP Shipley WU PSA bounces after neoadjuvant androgen deprivation and external beam radiation: Impact on definitions of failure Int J Radiat Oncol Biol Phys 2005 62 714-718 10.1016/ j.ijrobp.2004.11.020 15936550
15. Cox JGD Kaplan R Consensus statement: Guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 1997 37 1035-1041 10.1016/ S0360-3016(96)00584-6 9169810
16. Critz FA Williams WH Levinson AK Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: The relationship to patient age J Urol 2003 170 1864-1867 10.1097/01.ju.0000091644.41330.2a 14532794
17. Critz FA Williams WH Benton JB Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer J Urol 2000 163 1085-1089 10.1016/S0022-5347(05)67698-7 10737471
18. Rosser CJ Kamat AM Wang X Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer? Urology 2005 66 327-331 10.1016/ j.urology.2005.02.026 16040084
19. Stock RG Stone NN Cesaretti JA Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: Descriptions and implications Int J Radiat Oncol Biol Phys 2003 56 448-453 10.1016/ S0360-3016(02)04470-X 12738319
20. Patel C Elshaikh MA Angermeier K PSA bounce predicts early success in patients with permanent iodine-125 prostate implant Urology 2004 63 110-113 10.1016/j.urology.2003.08.025 14751360
21. Pickles T Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy Int J Radiat Oncol Biol Phys 2006
22. Merrick GS Butler WM Wallner KE Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy Brachytherapy 2003 2 181-188 10.1016/ S1538-4721(03)00130-2 15062141
23. Merrick GS Butler WM Wallner KE Prostate-specific antigen spikes after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 2002 54 450-456 10.1016/S0360-3016(02)02948-6 12243821
24. Demanes DJ Rodriguez RR Schour L High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results Int J Radiat Oncol Biol Phys 2005 61 1306-1316 10.1016/j.ijrobp.2004.08.014 15817332
25. Menard C Susil RC Choyke P MRI-guided HDR prostate brachytherapy in standard 1.5 T scanner Int J Radiat Oncol Biol Phys 2004 59 1414-1423 10.1016/j.ijrobp.2004.01.016 15275727
26. Citrin D Ning H Guion P Inverse treatment planning based on MRI for HDR prostate brachytherapy Int J Radiat Oncol Biol Phys 2005 61 1267-1275 10.1016/j.ijrobp.2004.11.024 15752909
27. D'Amico AV Moul JW Carroll PR Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure J Natl Cancer Inst 2004 96 509-515 15069112
28. Shipley WU Desilvio M Pilepich MV Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10 Int J Radiat Oncol Biol Phys 2006
29. Hanlon AL Pinover WH Horwitz EM Patterns and fate of PSA bouncing following 3D-CRT Int J Radiat Oncol Biol Phys 2001 50 845-849 10.1016/ S0360-3016(01)01557-7 11429210
30. Sengoz M Abacioglu U Cetin I PSA bouncing after external beam radiation for prostate cancer with or without hormonal treatment Eur Urol 2003 43 473-477 10.1016/S0302-2838(03)00138-6 12705989